-
CORTICOSTEROID AND BIOLOGIC USE IN A REAL-WORLD POPULATION WITH GENERALIZED MYASTHENIA GRAVIS IN THE UNITED STATES AND GERMANY
Mar 18, 2026, 21:38 PM -
THE IMPACTS OF TEEN BIRTH ON FEMALE ECONOMIC OUTCOMES: EVIDENCE FROM ABORTION ACCESS DATA
Mar 18, 2026, 21:38 PM -
HISTORIC PRICE DIFFERENTIALS AND MOST-FAVORED NATION PRESCRIPTION DRUG PRICING POLICY IMPACT: SCENARIO ANALYSIS USING POLI DATA ACROSS EIGHT GLOBAL MARKETS
Mar 18, 2026, 21:38 PM -
CLINICAL VALIDATION OF A MACHINE-LEARNING-ENRICHED IMMUNE-MEDIATED NECROTIZING MYOPATHY COHORT USING LINKED LABORATORY AND CLAIMS DATA
Mar 18, 2026, 21:38 PM -
PARENTAL BURNOUT AMONG MOTHERS: THE ROLE OF COPING STYLES AND PSYCHOLOGICAL FACTORS
Mar 18, 2026, 21:38 PM -
MAPPING QUALITY-OF-LIFE INSTRUMENTS IN JAPANESE HTA SUBMISSIONS: CURRENT PRACTICES AND FUTURE DIRECTIONS
Mar 18, 2026, 21:38 PM -
SHAME, EMBARRASSMENT, AND THREATS TO DATA VALIDITY DUE TO CONFUSING COA WORDING: EXPLORATION OF CONCEPTUAL OVERLAP IN CRITICAL COA TERMINOLOGY IN THE CONTEXT OF GLOBAL ADMINISTRATION - FROM THE LINGUISTS’ PERSPECTIVE
Mar 18, 2026, 21:38 PM -
THE IMPACT OF PHYSICAL FUNCTION ON HEALTHCARE RESOURCE USE AND CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE: A UK BIOBANK STUDY
Mar 18, 2026, 21:38 PM -
FROM DELAYS TO DETERIORATION: A REVIEW OF THE IMPACT OF PRIOR AUTHORIZATION ON PATIENT HEALTH
Mar 18, 2026, 21:38 PM -
USING A DISCRETE CHOICE EXPERIMENT TO EXPLORE PERIOPERATIVE TREATMENT PREFERENCES IN GASTRIC AND GASTROESOPHAGEAL CANCER
Mar 18, 2026, 21:38 PM -
GENERATIVE AI-ENABLED OBJECTION HANDLING TO SUPPORT PAYER ENGAGEMENT IN ADJUVANT MELANOMA THERAPY
Mar 18, 2026, 21:38 PM -
FACTORS ASSOCIATED WITH TREATMENT ENGAGEMENT AMONG EMERGENCY DEPARTMENT PATIENTS WITH OPIOID USE DISORDER AFTER DISCHARGE: A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
VALUE OF INFORMATION ANALYSIS FOR MANAGEMENT FOR INTERMITTENT CLAUDICATION: LLM-BASED RESULTS
Mar 18, 2026, 21:38 PM -
AGE AND GENDER HETEROGENEITY IN ADVERSE DRUG REACTIONS ASSOCIATED WITH HEMP USE: EVIDENCE FROM THE FDA PHARMACOVIGILANCE DATA IN THE LAST TWO DECADES
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN CLINICAL MANIFESTATIONS OF GOUT AND PATIENT REPORTED OUTCOME MEASURES: RESULTS OF A REAL-WORLD SURVEY IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
RECEIPT OF SARS-COV2 MRNA VACCINE PRIOR TO IMMUNE CHECKPOINT INHIBITOR THERAPY ASSOCIATED WITH SIGNIFICANTLY IMPROVED OVERALL SURVIVAL ACROSS MULTIPLE METASTATIC CANCERS: RESULTS FROM A REAL-WORLD EVIDENCE STUDY
Mar 18, 2026, 21:38 PM -
APALUTAMIDE (APA) AS FIRST OPTION TO METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) REPRESENTS COST-EFFECTIVE TREATMENT SEQUENCES TO HEALTH SYSTEMS
Mar 18, 2026, 21:38 PM -
AN ALGORITHM TO IDENTIFY LESS INVASIVE SURFACTANT ADMINISTRATION USING A REAL-WORLD DATABASE OF PRETERM INFANTS
Mar 18, 2026, 21:38 PM -
TRENDS IN PREVENTABLE HOSPITALIZATIONS BEFORE AND AFTER MEDICAID EXPANSION IN KENTUCKY
Mar 18, 2026, 21:38 PM -
THE ECONOMIC IMPACT OF PERIOPERATIVE IMMUNE CHECKPOINT INHIBITORS IN RESECTABLE GASTRIC AND GASTROESOPHAGEAL JUNCTION CANCERS IN A CANADIAN SETTING
Mar 18, 2026, 21:38 PM
